JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Last updated: 01 November 2019
Imfinzi (durvalumab), already approved for some bladder cancers, is now FDA approved for some patients with lung cancer.Read more
